Rialto Wealth Management LLC Buys New Shares in Aflac Incorporated (NYSE:AFL)

Rialto Wealth Management LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 400 shares of the financial services provider’s stock, valued at approximately $41,000.

Several other hedge funds have also recently made changes to their positions in the business. Whipplewood Advisors LLC acquired a new stake in Aflac during the fourth quarter worth approximately $26,000. Darwin Wealth Management LLC bought a new position in shares of Aflac during the 3rd quarter worth approximately $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac during the 4th quarter worth approximately $34,000. Raelipskie Partnership acquired a new stake in shares of Aflac during the 3rd quarter worth approximately $38,000. Finally, Covestor Ltd increased its stake in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares in the last quarter. 67.44% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AFL has been the topic of several research analyst reports. Evercore ISI reduced their price target on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Barclays cut their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. Morgan Stanley boosted their target price on Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. BMO Capital Markets assumed coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price target on the stock. Finally, Wells Fargo & Company decreased their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Wednesday, February 19th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Trading Up 0.5 %

NYSE AFL opened at $108.48 on Monday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $59.29 billion, a P/E ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The business has a fifty day simple moving average of $105.08 and a 200 day simple moving average of $107.73. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.